EUVIMEDEUVIMED entdecken
Crossref

Genetic Markers of Erythrocytosis: Can the Presence of JAK2 Mutation Be Determined via Complete Blood Count Parameters and/or Serum Erythropoietin Level?

Derya Koyun, Fatma Söylemez, Ömer Yakar

Ankara Üniversitesi Tıp Fakültesi Mecmuası · 27.03.2026 · 79 (1) · 98-107

DOI: 10.65092/autfm.1827667 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ankara Üniversitesi Tıp Fakültesi Mecmuası, online erschienen am 27.03.2026. Verfasst von Derya Koyun und 2 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In our study, we aimed to predict the presence of the JAK2V617F mutation using haemogram, biochemical parameters, and serum erythropoietin (EPO) levels in patients with erythrocytosis living at high altitudes.

Methods

In this retrospective study, 186 patients who presented with erythrocytosis between 2022 and 2025 and had resided at an altitude of ~1800 metres for at least one year were examined. The presence of erythrocytosis was determined according to the 2022 World Health Organisation criteria. Demographic, haematological, and biochemical parameters, as well as serum EPO levels, of the patients were compared according to the presence of the JAK2V617F mutation. Multivariate logistic regression and ROC analysis were then applied.

Results

The study included 186 patients; 151 (81.2%) were negative for the JAK2V617F mutation, and 35 (18.8%) were positive. Mutation-positive patients were significantly older ( p < 0.001). Univariate analyses revealed decreased levels of haemoglobin (p = 0.015), Mean Corpuscular Volume (MCV) (p = 0.029),Mean Corpuscular Hemoglobin (MCH) (p < 0.001), Mean Corpuscular Hemoglobin Concentration (MCHC) (p < 0.001), and EPO (p < 0.001). They significantly increased proliferative parameters, including Red Blood Cell Count (RBC) (p = 0.001), Platelet Count (PLT) (p < 0.001), Red Cell Distribution Width (RDW) (p

Zitieren

APA

Koyun, D., Söylemez, F., & Yakar, Ö. (2026). Genetic Markers of Erythrocytosis: Can the Presence of JAK2 Mutation Be Determined via Complete Blood Count Parameters and/or Serum Erythropoietin Level?. Ankara Üniversitesi Tıp Fakültesi Mecmuası, 79(1), 98-107. https://doi.org/10.65092/autfm.1827667

Vancouver

Koyun D, Söylemez F, Yakar Ö. Genetic Markers of Erythrocytosis: Can the Presence of JAK2 Mutation Be Determined via Complete Blood Count Parameters and/or Serum Erythropoietin Level?. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2026;79(1):98-107. doi:10.65092/autfm.1827667

BibTeX
@article{Koyun2026,
  author = {Koyun, Derya and Söylemez, Fatma and Yakar, Ömer},
  title = {Genetic Markers of Erythrocytosis: Can the Presence of JAK2 Mutation Be Determined via Complete Blood Count Parameters and/or Serum Erythropoietin Level?},
  journal = {Ankara Üniversitesi Tıp Fakültesi Mecmuası},
  year = {2026},
  volume = {79},
  number = {1},
  pages = {98--107},
  doi = {10.65092/autfm.1827667}
}
Kostenlos starten →